Skip To Main Content
Barbara E Mahon on Muck Rack

Barbara E Mahon

As seen in: Center for Disease Control and Prevention, JAMA: Journal of the American Medical Association, The Lancet, medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara E

Contact Barbara E, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Evaluating the relationship between summer season and infant salmonellosis in the United States

|
By Kathleen Fitzsimmons, Barbara E Mahon, Martha M Werler, Gates Foundation. Seattle
| medRxiv
The authors have declared no competing interest. This work was completed as part of the requirements of a PhD degree. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (13) Issue with article?

One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality

|
By Amanda C. Cohn, Infant Disorders, Developmental Disabilities, Barbara E Mahon
| JAMA: Journal of the American Medical Association Verified
One year after the first authorized COVID-19 vaccine was administered in the US, the nation celebrates a historic achievement in vaccine development and delivery. In 12 months, more than an estimated 200 million people in the US have completed their primary vaccine series. Vaccination has prevented millions of COVID-19 cases and hospitalizations and saved hundreds of thousands of lives.
Open in Who Shared Issue with article?

Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials

|
By Rebecca F. Grais, Stephen Kennedy, Barbara E Mahon, Sheri Dubey
| The Lancet Verified
Summary Background Establishment of immune correlates of protection can provide a measurable criterion for assessing protection against infection or disease. For some vaccines, such as the measles vaccine, antibodies serve as the correlate of protection, but for others, such as human papillomavirus, the correlate of protection remains unknown.
Open in Who Shared Issue with article?
See all 3 licensed articles (10 Total)